Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 3/20 | 0.47 |
| ▸ | CA9 | Q16790 | 3/20 | 0.47 |
| ▸ | CA12 | O43570 | 2/20 | 0.47 |
| ▸ | G6PD | P11413 | 1/20 | 0.46 |
| ▸ | STAT3 | P40763 | 1/20 | 0.45 |
| ▸ | PSMD10 | O75832 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 2/20 | 0.45 |
| ▸ | CA3 | P07451 | 1/20 | 0.45 |
| ▸ | CA6 | P23280 | 1/20 | 0.45 |
| ▸ | CA5A | P35218 | 1/20 | 0.45 |
| ▸ | CA7 | P43166 | 1/20 | 0.45 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.45 |
| ▸ | CYP24A1 | Q07973 | 2/20 | 0.44 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.43 |
| ▸ | VDR | P11473 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL890725 | 0.96 | ALDH1A1 (0.50) | ALDH1A1CYP3A4CYP2C9CYP2C19GAA | |
| SCHEMBL21618180 | 0.94 | ALDH1A1 (0.50) | ALDH1A1CYP3A4CYP2C9CYP2C19GAA | |
| SCHEMBL12737574 | 0.94 | ALDH1A1 (0.50) | ALDH1A1CYP3A4CYP2C9CYP2C19GAA | |
| SCHEMBL8484861 | 0.94 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9CYP2C19GAA | |
| SCHEMBL4815560 | 0.94 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9CYP2C19GAA | |
| SCHEMBL4812770 | 0.94 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9CYP2C19GAA | |
| SCHEMBL4951882 | 0.94 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9CYP2C19GAA | |
| SCHEMBL11050599 | 0.94 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9CYP2C19GAA | |
| SCHEMBL8483813 | 0.94 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9CYP2C19GAA | |
| SCHEMBL4954181 | 0.94 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CYP2C9CYP2C19GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 513 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2860169-A2 | Method for obtaining novel derivatives of naphtalene for the in vivo diagnosis of Alzheimer's disease | Centro De Neurociencias De Cuba (CU) | 2015-04-15 | — | — | EP | claimed |
| EP-2579377-B1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | UBE INDUSTRIES (JP) | 2014-09-03 | — | — | EP | claimed |
| CN-102989017-B | Application of berberine or its derivative in preparing tumor diagnosis imaging agent | WEST CHINA HOSPITAL SICHUAN UNIV | 2014-03-12 | — | — | CN | claimed |
| CN-102989017-A | Application of berberine or its derivative in preparing tumor diagnosis imaging agent | WEST CHINA HOSPITAL SICHUAN UNIV | 2013-03-27 | — | — | CN | claimed |
| US-20120321560-A1 | Method for Obtaining Novel Derivatives of Naphthalene for the In Vivo Diagnosis of Alzheimer's Disease | CENTRO DE NEUROCIENCIAS DE CUBA (CU) | 2012-12-20 | — | — | US | claimed |
| EP-2436666-A2 | METHOD FOR OBTAINING NOVEL DERIVATIVES OF NAPHTALENE FOR THE IN VIVO DIAGNOSIS OF ALZHEIMER 'S DISEASE | Centro De Neurociencias De Cuba (CU) | 2012-04-04 | — | — | EP | claimed |
| EP-1813987-B1 | SULFONIC-ESTER-CONTAINING COMPOSITION FOR FORMATION OF ANTIREFLECTION FILM FOR LITHOGRAPHY | NISSAN CHEMICAL IND LTD (JP) | 2011-08-24 | — | — | EP | claimed |
| US-6306203-B1 | FOR USE IN INK JET PRINTING, INCLUDING PIEZOELECTRIC INK JET PRINTING AND ACOUSTIC INK JET PRINTING | XEROX CORPORATION | 2001-10-23 | — | — | US | claimed |
| JP-11286490-A | — | — | None | — | — | JP | disclosed |
| JP-61260036-A | — | — | None | — | — | JP | disclosed |
| US-12565508-B2 | Group III and lanthanide bis-phenyl-phenoxy metal-ligand complexes | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-03-03 | — | — | US | disclosed |
| US-12497414-B2 | Group III and Lanthanide bis-phenyl-phenoxy metal-ligand complexes | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-12-16 | — | — | US | disclosed |
| US-20250257265-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY ELEMENT | NISSAN CHEMICAL CORPORATION (JP) | 2025-08-14 | — | — | US | disclosed |
| EP-4097151-B1 | GROUP III AND LANTHANIDE BIS-PHENYL-PHENOXY METAL-LIGAND COMPLEXES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-08-06 | — | — | EP | disclosed |
| US-5994391-A | HYPERLIPEMIC AGENTS; ANTICHOLESTEROL AGENTS | G.D. SEARLE AND COMPANY (US) | 1999-11-30 | — | — | US | disclosed |
| JP-H11286490-A | PRODUCTION OF MACROPOLYCYCLIC POLYAMIDE | CLARIANT GMBH | 1999-10-19 | — | — | JP | disclosed |
| EP-0940403-A2 | Process for the preparation of macropolycyclic polyamines | Clariant GmbH (DE) | 1999-09-08 | — | — | EP | disclosed |
| US-4701565-A | REACTING ALCOHOL WITH ORGANIC SULFONYL HALIDE TO FORM SULFONATE, REACTING SULFONATE WITH A PHENOL | FUJI PHOTO FILM CO., LTD. (JP) | 1987-10-20 | — | — | US | disclosed |
| JP-S61260036-A | PRODUCTION OF DIARYLOXYALKANE | FUJI PHOTO FILM CO LTD | 1986-11-18 | — | — | JP | disclosed |
| US-4097669-A | FUNGICIDES, BACTERICIDES, INSECTICIDES, ARTHROPODICIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1978-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120321560-A1 | Method for Obtaining Novel Derivatives of Naphthalene for the In Vivo Diagnosis of Alzheimer's Disease | SLC43A1, SLCO2B1, SLCO2A1 | ALDH1A1 1269/4885CYP3A4 2218/4885CYP2C9 1910/4885 |
| US-12565508-B2 | Group III and lanthanide bis-phenyl-phenoxy metal-ligand complexes | SCO2, CBR3, SOD1 | ALDH1A1 4089/4885CYP3A4 2390/4885CYP2C9 2010/4885 |
| US-12497414-B2 | Group III and Lanthanide bis-phenyl-phenoxy metal-ligand complexes | SSB, SOD1, LGALS3 | ALDH1A1 3746/4885CYP3A4 2438/4885CYP2C9 2473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.